医薬品有効成分市場、規模、シェア、動向、産業分析レポート：製品タイプ別、形態別、メーカータイプ別、用途別、地域別 - 市場予測 2025年～2034年

Polaris Market Research社の最新調査によると、医薬品有効成分（API）市場規模は2034年までに4,369億米ドルに達する見込みです。本レポートでは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

医薬品有効成分（API）市場の成長は、世界のジェネリック医薬品と一般用医薬品の需要増加が原動力となっています。例えば、米国における市販薬の小売売上高は、2000年の147億米ドルから2023年には434億米ドルに上昇しています。これは、2000年から2023年にかけて330億米ドルの大幅な増加を意味します。さらに、2018年から2023年までのOTC医薬品の売上高は3.6％増加しています。

公的および民間資本からの投資と資金調達の増加は、医薬品有効成分市場の成長を促進すると予想されます。医薬品の製剤化、生産、創薬期間の短縮における進歩は、投資に対するより良いリターンを求める投資家を惹きつけています。例えば、2024年8月、注射剤の主要企業であるビビント・ファーマは、ハイデラバードのゲノムバレーに高度な注射剤製造施設を建設する計画を発表しました。同社はこの新施設に4,800万米ドルを投資し、1,000人の雇用を創出するとともに、テランガナ州の世界のライフサイエンス拠点としての地位を強化する見込みです。この発表は、米国で行われたテランガナ州首相シュリ・A・レヴァンス・レッディ氏と産業・商業大臣シュリ・D・スリダール・バブ氏とのハイレベル会談の中で行われました。ビビント・ファーマは、すでにゲノムバレーに850万米ドルの研究開発センターを持っており、インドでの拠点を拡大しています。同社は国際市場への参入を支援するため、世界クラスのインフラとイノベーション・エコシステムで知られるゲノム・バレーに5.5エーカーの土地を取得しました。

製薬会社は医薬品有効成分の主要な消費者であり製造業者でもあります。投資の増加と政府の優遇措置により、革新的なアイデアを持つ新規参入企業が増加し、既存の大手製薬会社に課題しています。

医薬品有効成分（API）市場レポートハイライト

形態別分析では、水性セグメントはCAGRが大きく、市場の大幅な成長が見込まれます。この成長は、さまざまな形態の医薬品における水性原薬の幅広い用途に起因しています。

2024年には、北米がAPI市場を独占しました。

中国の医薬品有効成分（API）市場は、同国内のバイオテクノロジー革新に対する規制支援と資金提供により、大幅な成長が予測されています。

主な市場企業は、Pfizer; Teva Pharmaceuticals Industries Ltd.; GSK PLC; Sanofi; Eli Lilly and Company; Merck KGaA; AbbVie Inc.; F-Hoffman La Roche Ltd; AstraZeneca; Dr. Reddy's Laboratory Ltd.; BASF Corporation; Sun Pharmaceutical Industries Ltd.; Curia Global Inc.; and Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd.です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の医薬品有効成分（API）市場の洞察

• 市場スナップショット
• 医薬品有効成分（API）市場力学
  • 促進要因と機会
    • 医薬品分野への投資増加が市場規模を押し上げている
    • パイプライン医薬品の増加が市場の成長を牽引
  • 抑制要因と課題
    • 熟練労働力の不足
• PESTEL分析
• 医薬品有効成分（API）市場動向
• バリューチェーン分析
• COVID-19の影響分析

第5章 世界の医薬品有効成分（API）市場：製品タイプ別

• 主な調査結果
• イントロダクション
• モノクローナル抗体
• 免疫グロブリン
• サイトカイン
• インスリン
• ペプチドホルモン
• 血液因子
• ペプチド抗生物質
• ワクチン
• 低分子抗生物質
• 高効能医薬品有効成分（HPAPI）
• その他

第6章 世界の医薬品有効成分（API）市場：形態別

• 主な調査結果
• イントロダクション
• 水性液体
• 非水性液体
• 乾燥粉末

第7章 世界の医薬品有効成分（API）市場：メーカータイプ別

• 主な調査結果
• イントロダクション
• 自社向け
• 外販向け

第8章 世界の医薬品有効成分（API）市場：用途別

• 主な調査結果
• イントロダクション
• 心臓病学
• 腫瘍学
• 中枢神経系と神経学
• 整形外科
• 内分泌学
• 呼吸器科
• 消化器内科
• 腎臓学
• 眼科
• その他

第9章 世界の医薬品有効成分（API）市場：地域別

• 主な調査結果
• イントロダクション
  • 医薬品有効成分（API）市場評価：地域、2020～2034年
• 北米
  • 北米：製品タイプ別、2020～2034年
  • 北米：形態別、2020～2034年
  • 北米：メーカータイプ別、2020～2034年
  • 北米：アプリケーション別、2020～2034年
  • 米国
  • カナダ
• 欧州
  • 欧州：製品タイプ別、2020～2034年
  • 欧州：形態別、2020～2034年
  • 欧州：メーカータイプ別、2020～2034年
  • 欧州：アプリケーション別、2020～2034年
  • 英国
  • フランス
  • ドイツ
  • イタリア
  • スペイン
  • オランダ
  • ロシア
  • その他欧州
• アジア太平洋
  • アジア太平洋：製品タイプ別、2020～2034年
  • アジア太平洋：形態別、2020～2034年
  • アジア太平洋：メーカータイプ別、2020～2034年
  • アジア太平洋：アプリケーション別、2020～2034年
  • 中国
  • インド
  • マレーシア
  • 日本
  • インドネシア
  • 韓国
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ
  • 中東・アフリカ：製品タイプ別、2020～2034年
  • 中東・アフリカ：形態別、2020～2034年
  • 中東・アフリカ：メーカータイプ別、2020～2034年
  • 中東・アフリカ：アプリケーション別、2020～2034年
  • サウジアラビア
  • アラブ首長国連邦
  • イスラエル
  • 南アフリカ
  • その他中東とアフリカ
• ラテンアメリカ
  • ラテンアメリカ：製品タイプ別、2020～2034年
  • ラテンアメリカ：形態別、2020～2034年
  • ラテンアメリカ：メーカータイプ別、2020～2034年
  • ラテンアメリカ：アプリケーション別、2020～2034年
  • メキシコ
  • ブラジル
  • アルゼンチン
  • その他ラテンアメリカ

第10章 競合情勢

• 拡大と買収の分析
  • 拡大
  • 買収
• 提携/協業/合意/公開

第11章 企業プロファイル

• Pfizer
• Teva Pharmaceuticals Ltd
• GSK PLC
• Sanofi
• Eli Lilly and Company
• Merck KGaA
• AbbVie Inc.
• F-Hoffman La Roche Ltd
• AstraZeneca
• Dr. Reddy's Laboratory
• BASF Corporation
• Sun Pharmaceuticals Industries Ltd.
• Curia Global Inc.
• Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd.

List of Tables:

• Table 1 Global Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
• Table 2 Global Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
• Table 3 Global Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
• Table 4 Global Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
• Table 5 North America: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
• Table 6 North America: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
• Table 7 North America: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
• Table 8 North America: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
• Table 9 U.S.: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
• Table 10 U.S.: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
• Table 11 U.S.: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
• Table 12 U.S.: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
• Table 13 Canada: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
• Table 14 Canada: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
• Table 15 Canada: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
• Table 16 Canada: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
• Table 17 Europe: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
• Table 18 Europe: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
• Table 19 Europe: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
• Table 20 Europe: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
• Table 21 UK: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
• Table 22 UK: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
• Table 23 UK: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
• Table 24 UK: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
• Table 25 France: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
• Table 26 France: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
• Table 27 France: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
• Table 28 France: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
• Table 29 Germany: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
• Table 30 Germany: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
• Table 31 Germany: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
• Table 32 Germany: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
• Table 33 Italy: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
• Table 34 Italy: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
• Table 35 Italy: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
• Table 36 Italy: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
• Table 37 Spain: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
• Table 38 Spain: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
• Table 39 Spain: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
• Table 40 Spain: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
• Table 41 Netherlands: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
• Table 42 Netherlands: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
• Table 43 Netherlands: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
• Table 44 Netherlands: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
• Table 45 Russia: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
• Table 46 Russia: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
• Table 47 Russia: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
• Table 48 Russia: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
• Table 49 Rest of Europe: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
• Table 50 Rest of Europe: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
• Table 51 Rest of Europe: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
• Table 52 Rest of Europe: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
• Table 53 Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
• Table 54 Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
• Table 55 Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
• Table 56 Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
• Table 57 China: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
• Table 58 China: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
• Table 59 China: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
• Table 60 China: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
• Table 61 India: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
• Table 62 India: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
• Table 63 India: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
• Table 64 India: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
• Table 65 Malaysia: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
• Table 66 Malaysia: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
• Table 67 Malaysia: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
• Table 68 Malaysia: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
• Table 69 Japan: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
• Table 70 Japan: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
• Table 71 Japan: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
• Table 72 Japan: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
• Table 73 Indonesia: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
• Table 74 Indonesia: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
• Table 75 Indonesia: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
• Table 76 Indonesia: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
• Table 77 South Korea: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
• Table 78 South Korea: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
• Table 79 South Korea: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
• Table 80 South Korea: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
• Table 81 Australia: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
• Table 82 Australia: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
• Table 83 Australia: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
• Table 84 Australia: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
• Table 85 Rest of Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
• Table 86 Rest of Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
• Table 87 Rest of Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
• Table 88 Rest of Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
• Table 89 Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
• Table 90 Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
• Table 91 Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
• Table 92 Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
• Table 93 Saudi Arabia: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
• Table 94 Saudi Arabia: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
• Table 95 Saudi Arabia: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
• Table 96 Saudi Arabia: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
• Table 97 UAE: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
• Table 98 UAE: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
• Table 99 UAE: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
• Table 100 UAE: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
• Table 101 Israel: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
• Table 102 Israel: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
• Table 103 Israel: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
• Table 104 Israel: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
• Table 105 South Africa: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
• Table 106 South Africa: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
• Table 107 South Africa: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
• Table 108 South Africa: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
• Table 109 Rest of Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
• Table 110 Rest of Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
• Table 111 Rest of Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
• Table 112 Rest of Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
• Table 113 Latin America: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
• Table 114 Latin America: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
• Table 115 Latin America: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
• Table 116 Latin America: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
• Table 117 Mexico: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
• Table 118 Mexico: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
• Table 119 Mexico: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
• Table 120 Mexico: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
• Table 121 Brazil: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
• Table 122 Brazil: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
• Table 123 Brazil: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
• Table 124 Brazil: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
• Table 125 Argentina: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
• Table 126 Argentina: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
• Table 127 Argentina: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
• Table 128 Argentina: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
• Table 129 Rest of Latin America: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
• Table 130 Rest of Latin America: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
• Table 131 Rest of Latin America: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
• Table 132 Rest of Latin America: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
• List of Figures:
• Figure 1. Global Active Pharmaceutical Ingredient (API) Market, 2020-2034 (USD Billion)
• Figure 2. Integrated Ecosystem
• Figure 3. Research Methodology: Top-Down & Bottom-Up Price
• Figure 4. Market by Geography
• Figure 5. Porter's Five Forces
• Figure 6. Market by Product Type
• Figure 7. Global Active Pharmaceutical Ingredient (API) Market, by Product Type, 2024 & 2034 (USD Billion)
• Figure 8. Market by Form
• Figure 9. Global Active Pharmaceutical Ingredient (API) Market, by Form, 2024 & 2034 (USD Billion)
• Figure 10. Market by Manufacturer Type
• Figure 11. Global Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2024 & 2034 (USD Billion)
• Figure 12. Market by Application
• Figure 13. Global Active Pharmaceutical Ingredient (API) Market, by Application, 2024 & 2034 (USD Billion)

The active pharmaceutical ingredient market size is expected to reach USD 436.90 billion by 2034, according to a new study by Polaris Market Research. The report "Active Pharmaceutical Ingredient (API) Market Size, Share, Trends, Industry Analysis Report: By Product Type, Form (Aqueous, Non-Aqueous Liquid, and Dry Powder), Manufacturer Type, Application, and Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The active pharmaceutical ingredient (API) market growth is driven by increasing demand for generic drugs and over-the-counter drugs worldwide. For instance, the retail sales of over-the-counter drugs in the US have risen to 43.4 billion USD in 2023 from 14.7 billion dollar USD in 2000. This represents a significant increase of 33 billion dollar USD from 2000 to 2023. Additionally, the sales revenue of OTC drugs from 2018 to 2023 has grown by 3.6%

Increasing investments and funding from public and private capitalists are anticipated to fuel active pharmaceutical market growth. Advancements in drug formulations, production, and short drug discovery timelines have been attracting investors seeking better returns on their investments. For instance, in August 2024, Vivint Pharma, a leading injectables pharmaceutical company, announced plans to build an advanced injectables manufacturing facility in Genome Valley, Hyderabad. The company will invest $48 million in the new facility, which is expected to create 1,000 jobs and strengthen Telangana's position as a global life sciences hub. The announcement was made during a high-level meeting with Telangana's Chief Minister, Shri A. Revanth Reddy, and Minister for Industries and Commerce, Sri D. Sridhar Babu, in the US. Vivint Pharma, which already has a $8.5 million R&D center in Genome Valley, is expanding its footprint in India. The company has acquired 5.5 acres in Genome Valley, known for its world-class infrastructure and innovation ecosystem, to support its entry into international markets.

Pharmaceutical companies are major consumers and manufacturers of active pharmaceutical ingredients. Increasing investment and government incentives have led to a rise in the number of new players with innovative ideas, challenging the existing pharmaceutical giants.

Active Pharmaceutical Ingredient (API) Market Report Highlights

By form analysis, the aqueous segment is anticipated to experience substantial growth with a significant CAGR in the market. This growth is attributed to the wide range of applications of the aqueous active pharmaceutical ingredient in different forms of drugs.

In 2024, North America dominated the API market due to the established presence of several companies within the region.

The active pharmaceutical ingredient (API) market in China is projected for substantial growth due to the regulatory support and funding for biotech innovations within the country.

The key market players are Pfizer; Teva Pharmaceuticals Industries Ltd.; GSK PLC; Sanofi; Eli Lilly and Company; Merck KGaA; AbbVie Inc.; F-Hoffman La Roche Ltd; AstraZeneca; Dr. Reddy's Laboratory Ltd.; BASF Corporation; Sun Pharmaceutical Industries Ltd.; Curia Global Inc.; and Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd.

Polaris Market Research has segmented the active pharmaceutical ingredient market report based on product type, form, manufacturer type, application, and region:

By Product Type Outlook (Revenue - USD Billion, 2020-2034)

• mAb
• Immunoglobulin
• Cytokines
• Insulin
• Peptide Hormones
• Blood Factors
• Peptide Antibiotics
• Vaccines
• Small Molecule Antibiotics
• Highly Potent Active Pharmaceutical Ingredient (HPAPI)
• Others

By Form Outlook (Revenue - USD Billion, 2020-2034)

• Aqueous
• Non-Aqueous Liquid
• Dry Powder

By Manufacturer Type Outlook (Revenue - USD Billion, 2020-2034)

• Captive
• Merchant

By Application Outlook (Revenue - USD Billion, 2020-2034)

• Cardiology
• Oncology
• CNS & Neurology
• Orthopedic
• Endocrinology
• Pulmonology
• Gastroenterology
• Nephrology
• Ophthalmology
• Others

By Regional Outlook (Revenue - USD Billion, 2020-2034)

• North America
• US
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Netherlands
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Malaysia
• Australia
• Rest of Asia Pacific
• Latin America
• Argentina
• Brazil
• Mexico
• Rest of Latin America
• Middle East & Africa
• UAE
• Saudi Arabia
• Israel
• South Africa
• Rest of the Middle East & Africa

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global Active Pharmaceutical Ingredient (API) Market Insights

• 4.1. Active Pharmaceutical Ingredient (API) Market - Market Snapshot
• 4.2. Active Pharmaceutical Ingredient (API) Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Increasing Investment in Pharmaceutical Sector is Driving the Market Size
    • 4.2.1.2. Increasing Number of Pipeline Drugs Are Driving the Market Growth
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. Lack of Skilled Workforce
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTEL Analysis
• 4.5. Active Pharmaceutical Ingredient (API) Market Trends
• 4.6. Value Chain Analysis
• 4.7. COVID-19 Impact Analysis

5. Global Active Pharmaceutical Ingredient (API) Market, by Product Type

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
• 5.3. mAb
  • 5.3.1. Global Active Pharmaceutical Ingredient (API) Market, by mAb, by Region, 2020-2034 (USD Billion)
• 5.4. Immunoglobulin
  • 5.4.1. Global Active Pharmaceutical Ingredient (API) Market, by Immunoglobulin, by Region, 2020-2034 (USD Billion)
• 5.5. Cytokines
  • 5.5.1. Global Active Pharmaceutical Ingredient (API) Market, by Cytokines, by Region, 2020-2034 (USD Billion)
• 5.6. Insulin
  • 5.6.1. Global Active Pharmaceutical Ingredient (API) Market, by Insulin, by Region, 2020-2034 (USD Billion)
• 5.7. Peptide Hormones
  • 5.7.1. Global Active Pharmaceutical Ingredient (API) Market, by Peptide Hormones, by Region, 2020-2034 (USD Billion)
• 5.8. Blood Factors
  • 5.8.1. Global Active Pharmaceutical Ingredient (API) Market, by Blood Factors, by Region, 2020-2034 (USD Billion)
• 5.9. Peptide Antibiotics
  • 5.9.1. Global Active Pharmaceutical Ingredient (API) Market, by Peptide Antibiotics, by Region, 2020-2034 (USD Billion)
• 5.10. Vaccines
  • 5.10.1. Global Active Pharmaceutical Ingredient (API) Market, by Vaccines, by Region, 2020-2034 (USD Billion)
• 5.11. Small Molecule Antibiotics
  • 5.11.1. Global Active Pharmaceutical Ingredient (API) Market, by Small Molecule Antibiotics, by Region, 2020-2034 (USD Billion)
• 5.12. Highly Potent Active Pharmaceutical Ingredient (HPAPI)
  • 5.12.1. Global Active Pharmaceutical Ingredient (API) Market, by Highly Potent Active Pharmaceutical Ingredient (HPAPI), by Region, 2020-2034 (USD Billion)
• 5.13. Others
  • 5.13.1. Global Active Pharmaceutical Ingredient (API) Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Active Pharmaceutical Ingredient (API) Market, by Form

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
• 6.3. Aqueous
  • 6.3.1. Global Active Pharmaceutical Ingredient (API) Market, by Aqueous, by Region, 2020-2034 (USD Billion)
• 6.4. Non-Aqueous Liquid
  • 6.4.1. Global Active Pharmaceutical Ingredient (API) Market, by Non-Aqueous Liquid, by Region, 2020-2034 (USD Billion)
• 6.5. Dry Powder
  • 6.5.1. Global Active Pharmaceutical Ingredient (API) Market, by Dry Powder, by Region, 2020-2034 (USD Billion)

7. Global Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Global Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
• 7.3. Captive
  • 7.3.1. Global Active Pharmaceutical Ingredient (API) Market, by Captive, by Region, 2020-2034 (USD Billion)
• 7.4. Merchant
  • 7.4.1. Global Active Pharmaceutical Ingredient (API) Market, by Merchant, by Region, 2020-2034 (USD Billion)

8. Global Active Pharmaceutical Ingredient (API) Market, by Application

• 8.1. Key Findings
• 8.2. Introduction
  • 8.2.1. Global Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
• 8.3. Cardiology
  • 8.3.1. Global Active Pharmaceutical Ingredient (API) Market, by Cardiology, by Region, 2020-2034 (USD Billion)
• 8.4. Oncology
  • 8.4.1. Global Active Pharmaceutical Ingredient (API) Market, by Oncology, by Region, 2020-2034 (USD Billion)
• 8.5. CNS & Neurology
  • 8.5.1. Global Active Pharmaceutical Ingredient (API) Market, by CNS & Neurology, by Region, 2020-2034 (USD Billion)
• 8.6. Orthopedic
  • 8.6.1. Global Active Pharmaceutical Ingredient (API) Market, by Orthopedic, by Region, 2020-2034 (USD Billion)
• 8.7. Endocrinology
  • 8.7.1. Global Active Pharmaceutical Ingredient (API) Market, by Endocrinology, by Region, 2020-2034 (USD Billion)
• 8.8. Pulmonology
  • 8.8.1. Global Active Pharmaceutical Ingredient (API) Market, by Pulmonology, by Region, 2020-2034 (USD Billion)
• 8.9. Gastroenterology
  • 8.9.1. Global Active Pharmaceutical Ingredient (API) Market, by Gastroenterology, by Region, 2020-2034 (USD Billion)
• 8.10. Nephrology
  • 8.10.1. Global Active Pharmaceutical Ingredient (API) Market, by Nephrology, by Region, 2020-2034 (USD Billion)
• 8.11. Ophthalmology
  • 8.11.1. Global Active Pharmaceutical Ingredient (API) Market, by Nephrology, by Region, 2020-2034 (USD Billion)
• 8.12. Others
  • 8.12.1. Global Active Pharmaceutical Ingredient (API) Market, by Others, by Region, 2020-2034 (USD Billion)

9. Global Active Pharmaceutical Ingredient (API) Market, by Geography

• 9.1. Key Findings
• 9.2. Introduction
  • 9.2.1. Active Pharmaceutical Ingredient (API) Market Assessment, By Geography, 2020-2034 (USD Billion)
• 9.3. Active Pharmaceutical Ingredient (API) Market - North America
  • 9.3.1. North America: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  • 9.3.2. North America: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  • 9.3.3. North America: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  • 9.3.4. North America: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • 9.3.5. Active Pharmaceutical Ingredient (API) Market - U.S.
    • 9.3.5.1. U.S.: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
    • 9.3.5.2. U.S.: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
    • 9.3.5.3. U.S.: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
    • 9.3.5.4. U.S.: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • 9.3.6. Active Pharmaceutical Ingredient (API) Market - Canada
    • 9.3.6.1. Canada: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
    • 9.3.6.2. Canada: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
    • 9.3.6.3. Canada: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
    • 9.3.6.4. Canada: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
• 9.4. Active Pharmaceutical Ingredient (API) Market - Europe
  • 9.4.1. Europe: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  • 9.4.2. Europe: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  • 9.4.3. Europe: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  • 9.4.4. Europe: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • 9.4.5. Active Pharmaceutical Ingredient (API) Market - UK
    • 9.4.5.1. UK: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
    • 9.4.5.2. UK: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
    • 9.4.5.3. UK: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
    • 9.4.5.4. UK: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • 9.4.6. Active Pharmaceutical Ingredient (API) Market - France
    • 9.4.6.1. France: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
    • 9.4.6.2. France: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
    • 9.4.6.3. France: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
    • 9.4.6.4. France: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • 9.4.7. Active Pharmaceutical Ingredient (API) Market - Germany
    • 9.4.7.1. Germany: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
    • 9.4.7.2. Germany: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
    • 9.4.7.3. Germany: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
    • 9.4.7.4. Germany: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • 9.4.8. Active Pharmaceutical Ingredient (API) Market - Italy
    • 9.4.8.1. Italy: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
    • 9.4.8.2. Italy: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
    • 9.4.8.3. Italy: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
    • 9.4.8.4. Italy: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • 9.4.9. Active Pharmaceutical Ingredient (API) Market - Spain
    • 9.4.9.1. Spain: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
    • 9.4.9.2. Spain: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
    • 9.4.9.3. Spain: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
    • 9.4.9.4. Spain: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • 9.4.10. Active Pharmaceutical Ingredient (API) Market - Netherlands
    • 9.4.10.1. Netherlands: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
    • 9.4.10.2. Netherlands: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
    • 9.4.10.3. Netherlands: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
    • 9.4.10.4. Netherlands: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • 9.4.11. Active Pharmaceutical Ingredient (API) Market - Russia
    • 9.4.11.1. Russia: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
    • 9.4.11.2. Russia: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
    • 9.4.11.3. Russia: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
    • 9.4.11.4. Russia: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • 9.4.12. Active Pharmaceutical Ingredient (API) Market - Rest of Europe
    • 9.4.12.1. Rest of Europe: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
    • 9.4.12.2. Rest of Europe: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
    • 9.4.12.3. Rest of Europe: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
    • 9.4.12.4. Rest of Europe: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
• 9.5. Active Pharmaceutical Ingredient (API) Market - Asia Pacific
  • 9.5.1. Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  • 9.5.2. Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  • 9.5.3. Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  • 9.5.4. Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • 9.5.5. Active Pharmaceutical Ingredient (API) Market - China
    • 9.5.5.1. China: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
    • 9.5.5.2. China: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
    • 9.5.5.3. China: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
    • 9.5.5.4. China: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • 9.5.6. Active Pharmaceutical Ingredient (API) Market - India
    • 9.5.6.1. India: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
    • 9.5.6.2. India: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
    • 9.5.6.3. India: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
    • 9.5.6.4. India: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • 9.5.7. Active Pharmaceutical Ingredient (API) Market - Malaysia
    • 9.5.7.1. Malaysia: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
    • 9.5.7.2. Malaysia: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
    • 9.5.7.3. Malaysia: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
    • 9.5.7.4. Malaysia: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • 9.5.8. Active Pharmaceutical Ingredient (API) Market - Japan
    • 9.5.8.1. Japan: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
    • 9.5.8.2. Japan: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
    • 9.5.8.3. Japan: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
    • 9.5.8.4. Japan: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • 9.5.9. Active Pharmaceutical Ingredient (API) Market - Indonesia
    • 9.5.9.1. Indonesia: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
    • 9.5.9.2. Indonesia: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
    • 9.5.9.3. Indonesia: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
    • 9.5.9.4. Indonesia: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • 9.5.10. Active Pharmaceutical Ingredient (API) Market - South Korea
    • 9.5.10.1. South Korea: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
    • 9.5.10.2. South Korea: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
    • 9.5.10.3. South Korea: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
    • 9.5.10.4. South Korea: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • 9.5.11. Active Pharmaceutical Ingredient (API) Market - Australia
    • 9.5.11.1. Australia: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
    • 9.5.11.2. Australia: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
    • 9.5.11.3. Australia: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
    • 9.5.11.4. Australia: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • 9.5.12. Active Pharmaceutical Ingredient (API) Market - Rest of Asia Pacific
    • 9.5.12.1. Rest of Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
    • 9.5.12.2. Rest of Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
    • 9.5.12.3. Rest of Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
    • 9.5.12.4. Rest of Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
• 9.6. Active Pharmaceutical Ingredient (API) Market - Middle East & Africa
  • 9.6.1. Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  • 9.6.2. Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  • 9.6.3. Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  • 9.6.4. Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • 9.6.5. Active Pharmaceutical Ingredient (API) Market - Saudi Arabia
    • 9.6.5.1. Saudi Arabia: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
    • 9.6.5.2. Saudi Arabia: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
    • 9.6.5.3. Saudi Arabia: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
    • 9.6.5.4. Saudi Arabia: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • 9.6.6. Active Pharmaceutical Ingredient (API) Market - UAE
    • 9.6.6.1. UAE: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
    • 9.6.6.2. UAE: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
    • 9.6.6.3. UAE: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
    • 9.6.6.4. UAE: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • 9.6.7. Active Pharmaceutical Ingredient (API) Market - Israel
    • 9.6.7.1. Israel: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
    • 9.6.7.2. Israel: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
    • 9.6.7.3. Israel: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
    • 9.6.7.4. Israel: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • 9.6.8. Active Pharmaceutical Ingredient (API) Market - South Africa
    • 9.6.8.1. South Africa: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
    • 9.6.8.2. South Africa: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
    • 9.6.8.3. South Africa: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
    • 9.6.8.4. South Africa: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • 9.6.9. Active Pharmaceutical Ingredient (API) Market - Rest of Middle East & Africa
    • 9.6.9.1. Rest of Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
    • 9.6.9.2. Rest of Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
    • 9.6.9.3. Rest of Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
    • 9.6.9.4. Rest of Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
• 9.7. Active Pharmaceutical Ingredient (API) Market - Latin America
  • 9.7.1. Latin America: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  • 9.7.2. Latin America: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  • 9.7.3. Latin America: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  • 9.7.4. Latin America: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • 9.7.5. Active Pharmaceutical Ingredient (API) Market - Mexico
    • 9.7.5.1. Mexico: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
    • 9.7.5.2. Mexico: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
    • 9.7.5.3. Mexico: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
    • 9.7.5.4. Mexico: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • 9.7.6. Active Pharmaceutical Ingredient (API) Market - Brazil
    • 9.7.6.1. Brazil: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
    • 9.7.6.2. Brazil: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
    • 9.7.6.3. Brazil: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
    • 9.7.6.4. Brazil: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • 9.7.7. Active Pharmaceutical Ingredient (API) Market - Argentina
    • 9.7.7.1. Argentina: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
    • 9.7.7.2. Argentina: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
    • 9.7.7.3. Argentina: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
    • 9.7.7.4. Argentina: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • 9.7.8. Active Pharmaceutical Ingredient (API) Market - Rest of Latin America
    • 9.7.8.1. Rest of Latin America: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
    • 9.7.8.2. Rest of Latin America: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
    • 9.7.8.3. Rest of Latin America: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
    • 9.7.8.4. Rest of Latin America: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)

10. Competitive Landscape

• 10.1. Expansion and Acquisition Analysis
  • 10.1.1. Expansion
  • 10.1.2. Acquisitions
• 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

• 11.1. Pfizer
  • 11.1.1. Company Overview
  • 11.1.2. Financial Performance
  • 11.1.3. Product Benchmarking
  • 11.1.4. Recent Development
• 11.2. Teva Pharmaceuticals Ltd
  • 11.2.1. Company Overview
  • 11.2.2. Financial Performance
  • 11.2.3. Product Benchmarking
  • 11.2.4. Recent Development
• 11.3. GSK PLC
  • 11.3.1. Company Overview
  • 11.3.2. Financial Performance
  • 11.3.3. Product Benchmarking
  • 11.3.4. Recent Development
• 11.4. Sanofi
  • 11.4.1. Company Overview
  • 11.4.2. Financial Performance
  • 11.4.3. Product Benchmarking
  • 11.4.4. Recent Development
• 11.5. Eli Lilly and Company
  • 11.5.1. Company Overview
  • 11.5.2. Financial Performance
  • 11.5.3. Product Benchmarking
  • 11.5.4. Recent Development
• 11.6. Merck KGaA
  • 11.6.1. Company Overview
  • 11.6.2. Financial Performance
  • 11.6.3. Product Benchmarking
  • 11.6.4. Recent Development
• 11.7. AbbVie Inc.
  • 11.7.1. Company Overview
  • 11.7.2. Financial Performance
  • 11.7.3. Product Benchmarking
  • 11.7.4. Recent Development
• 11.8. F-Hoffman La Roche Ltd
  • 11.8.1. Company Overview
  • 11.8.2. Financial Performance
  • 11.8.3. Product Benchmarking
  • 11.8.4. Recent Development
• 11.9. AstraZeneca
  • 11.9.1. Company Overview
  • 11.9.2. Financial Performance
  • 11.9.3. Product Benchmarking
  • 11.9.4. Recent Development
• 11.10. Dr. Reddy's Laboratory
  • 11.10.1. Company Overview
  • 11.10.2. Financial Performance
  • 11.10.3. Product Benchmarking
  • 11.10.4. Recent Development
• 11.11. BASF Corporation
  • 11.11.1. Company Overview
  • 11.11.2. Financial Performance
  • 11.11.3. Product Benchmarking
  • 11.11.4. Recent Development
• 11.12. Sun Pharmaceuticals Industries Ltd.
  • 11.12.1. Company Overview
  • 11.12.2. Financial Performance
  • 11.12.3. Product Benchmarking
  • 11.12.4. Recent Development
• 11.13. Curia Global Inc.
  • 11.13.1. Company Overview
  • 11.13.2. Financial Performance
  • 11.13.3. Product Benchmarking
  • 11.13.4. Recent Development
• 11.14. Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd.
  • 11.14.1. Company Overview
  • 11.14.2. Financial Performance
  • 11.14.3. Product Benchmarking
  • 11.14.4. Recent Development